Poland· PL-100412716
Aklief
A trifarotene product containing trifarotenum, registered in Poland by Galderma Polska Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Trifarotene is registered in 15 of 19 countries.
Countries holding a registration under ATC D10AD06 (trifarotene), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Trifarotene · ATC D10AD06
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Trifarotenum
- Manufacturer
- Galderma Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D10AD06
- ATC class
- Trifarotene
- Defined daily dose
- 50 mcg, T
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991427870
- gtin05909991427887
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
9 interactions on record for trifarotene.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trifarotene · interactions on record
9 records
- 1 severe
- 8 moderate
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Salicylic acidD01AE12moderate
- IsotretinoinD10AD04moderate
- Benzoyl peroxideD10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Trifarotene in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAKLIEFGalderma International, La Défense
- FinlandAkliefGalderma Nordic AB
- IrelandAklief 50 microgram/g CreamGalderma International
- NetherlandsAklief 50 microgram/g crèmeGalderma Benelux B.V.
- NorwayAkliefGalderma Nordic AB
- SwedenAklief 50 mikrogram/g KrämGalderma Nordic AB
- SwitzerlandAklief
- United StatesAKLIEFGalderma Laboratories, L.P.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Belgium · Aklief
- Bulgaria · Аклиеф
- Cyprus · Selgamis
- Czechia · Aklief
- Germany · Selgamis
- Denmark · Aklief
- Estonia · Aklief
- Spain · Aklief
- Finland · Aklief
- France · Aklief
- United Kingdom (Northern Ireland) · Aklief
- Greece · Selgamis
- Croatia · Aklief
- Hungary · Aklief
- Ireland · Aklief
- Iceland · Aklief
- Italy · Selgamis
- Lithuania · Aklief
- Luxembourg · Aklief
- Latvia · Aklief
- Malta · Aklief
- Netherlands · Aklief
- Norway · Aklief
- Portugal · Aklief
- Romania · Aklief
- Sweden · Aklief
- Slovakia · Aklief
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a99f547f-6e9c-47d6-9811-54a8f32acce7 GET /v1/drugs/a99f547f-6e9c-47d6-9811-54a8f32acce7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "50 mcg/g",
"packaging": "05909991427870 ¦ Rp ¦ 136070\n1 poj. 30 g\n05909991427887 ¦ Rp ¦ 136071\n1 poj. 75 g",
"substance": "Trifarotenum 50 mcg/g",
"common_name": "Trifarotenum",
"pl_product_id": "100412716",
"pozwolenie_nr": "25839",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about trifarotene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.